Table 3 Multivariate analysis of clinicopathological factors for overall survival in BC patients
From: Role of BC040587 as a predictor of poor outcome in breast cancer
HR | 95.0% CI | pvalue | ||
|---|---|---|---|---|
Variable | Lower | Upper | ||
Lymph node(positive/negative) | 3.891 | 1.014 | 14.907 | 0.047 |
TNM(I + II/III) | 0.152 | 0.021 | 1.103 | 0.063 |
HR status (positive/negative) | 0.335 | 0.112 | 1.000 | 0.050 |
HER2 status (positive/negative) | 1.663 | 0.581 | 4.763 | 0.343 |
BC040587 (high/low) | 0.248 | 0.069 | 0.890 | 0.032 |